Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Tickers AMBO AMD DBGI DJT
Tags GLYC Losers AMD
From Benzinga
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Tickers AMGN AZN CTLT GPCR
Tags Health Care AZN Large Cap
From Benzinga
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
Tickers JAZZ NEWS RHHBY
Tags JAZZ Stories That Matter General
From Benzinga
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Tickers ALT AMGN LLY NEWS
Tags AI Generated Large Cap PFE
From Benzinga
Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday?
Tickers NEWS RHHBY TPST
Tags Health Care Equities Contracts
From Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
Tickers ABBV BPTH NEWS RHHBY
Tags Market News BPTH Benzinga
From Benzinga
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
Tickers BIIB NEWS RHHBY SRRK
Tags Market News Benzinga SRRK
From Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
Tickers RHHBY RXRX SNY SOUN
Tags SNY RXRX BAYR/Y
From Motley Fool
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
Tickers LLY NEWS NVO RHHBY
Tags Markets News Justin Wolfers
From Benzinga
3 Top Stocks That Could Still Rocket Higher in 2024
Tickers BBIO PFE PTCT RHHBY
Tags Market News PFE VRTX
From Motley Fool
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
Tickers LLY NEWS NVO RHHBY
Tags Eurozone Top Stories Stories That Matter
From Benzinga
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
Tickers NEWS RHHBY
Tags Briefs News Biotech
From Benzinga
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
Tickers ALT AMZN HIMS LLY
Tags HIMS NVDA VKTX
From Motley Fool
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
Tickers NEWS RHHBY
Tags Market News FDA Benzinga
From Benzinga
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
Tickers RHHBY VKTX
Tags Market News RHHBY Recent Press Releases
From Motley Fool
Why Roche Holdings Stock Withered on Wednesday
Tickers LLY NVO RHHBY
Tags Recent Press Releases RHHBY NVO
From Motley Fool
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
Tickers FULC NEWS RHHBY RNA
Tags Price Target News Briefs
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags RHHBY General why it's moving
From Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
Tickers BNTX MRK MRNA NEWS
Tags Large Cap Biotech MRNA
From Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Tickers ABT BVNKF BVNRY DGX
Tags Top Stories General RHHBY
From Benzinga
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
Tickers LLY NVO RHHBY
Tags NVO LLY RHHBY
From Motley Fool
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
Tickers LLY NEWS NVO RHHBY
Tags General RHHBY Briefs
From Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
Tickers NEWS RHHBY TPST
Tags RHHBY General News
From Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
Tickers LLY NVO RHHBY
Tags LLY NVO Recent Press Releases
From Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Tickers ABBV BMY NEWS RHHBY
Tags Top Stories Stories That Matter News
From Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
Tickers MRK NEWS RHHBY
Tags MRK Market News Benzinga
From Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
Tickers AMGN LLY NVO PFE
Tags Market News VKTX NVO
From Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
Tickers C GOOG GOOGL NEWS
Tags M&A RHHBY General
From Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
Tickers AGEN BMY MRK NEWS
Tags why it's moving Briefs News
From Benzinga
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Tickers ALT LLY NVO PFE
Tags RHHBY Recent Press Releases ALT
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.